Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical News Today (MNT)
As GLP‑1 medications become widely used for obesity and metabolic disease, clinicians are confronting a growing question: What should be done when patients don’t respond as expected?
Endocrinology & Diabetes Nursing April 22nd 2026